Excimer laser coronary angioplasty in acute myocardial infarction

Area of Science:

• Cardiology
• Interventional Cardiology
• Vascular Medicine

Background:

• Acute myocardial infarction (AMI) remains a leading cause of mortality worldwide.
• Timely restoration of blood flow is critical for myocardial salvage.
• Percutaneous coronary intervention is a standard treatment, but alternative approaches are continually explored.

Purpose of the Study:

• To evaluate the short-term efficacy and safety of percutaneous excimer laser angioplasty (PELA) in patients with acute myocardial infarction.
• To assess procedural success rates, complication incidence, and early hemodynamic outcomes.

Main Methods:

• A prospective study involving 18 patients (16 male, 2 female; mean age 56.6 years) with AMI.
• PELA was performed to address severe stenosis (97.9%).
• Laser angioplasty utilized a mean of 808 pulses, followed by stent implantation in all cases.

Main Results:

• Successful lesion crossing was achieved in all patients.
• A high success rate for laser ablation (94%) was observed.
• Excellent distal flow (TIMI grade 3) was restored in 94% of patients post-procedure.
• Significant ST-segment resolution (>70%) occurred in 78% of patients within 90 minutes.
• A low rate of type C dissection (6%) was noted.

Conclusions:

• Percutaneous excimer laser angioplasty is an effective and reliable treatment modality for acute myocardial infarction.
• The procedure demonstrates a favorable safety profile with high rates of successful reperfusion.
• PELA, combined with stenting, facilitates rapid restoration of coronary blood flow in AMI patients.